Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/de-gruyter/acute-side-effects-after-definitive-stereotactic-body-radiation-pvJxTYSuR3
References (46)
-
A. Katz, Josephine Kang (2014)
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year StudyFrontiers in Oncology, 4
-
Nicholas Zaorsky, M. Studenski, A. Dicker, L. Gomella, R. Den (2013)
Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?Cancer treatment reviews, 39 3
-
A. D'Amico, J. Moul, P. Carroll, Leon Sun, D. Lubeck, Ming-Hui Chen (2003)
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 11
-
D. Brenner, E. Hall (1999)
Fractionation and protraction for radiotherapy of prostate carcinoma.International journal of radiation oncology, biology, physics, 43 5
-
J. Ferlay, M. Colombet, I. Soerjomataram, T. Dyba, G. Randi, M. Bettio, A. Gavin, O. Visser, F. Bray (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.European journal of cancer, 103
-
J. Cox, J. Stetz, T. Pajak (1995)
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)International journal of radiation oncology, biology, physics, 31 5
-
A. Loblaw, P. Cheung, L. D’Alimonte, A. Deabreu, A. Mamedov, Liying Zhang, Colin Tang, H. Quon, S. Jain, G. Pang, R. Nam (2013)
Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 107 2
-
C. King, J. Brooks, H. Gill, J. Presti (2012)
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.International journal of radiation oncology, biology, physics, 82 2
-
A. Widmark, A. Gunnlaugsson, L. Beckman, C. Thellenberg-Karlsson, M. Høyer, M. Lagerlund, J. Kindblom, C. Ginman, B. Johansson, K. Björnlinger, M. Seke, M. Agrup, P. Fransson, B. Tavelin, David Norman, B. Zackrisson, H. Anderson, E. Kjellén, L. Franzén, P. Nilsson (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trialThe Lancet, 394
-
C. Oliai, R. Lanciano, Brian Sprandio, Jun Yang, J. Lamond, S. Arrigo, M. Good, M. Mooreville, B. Garber, L. Brady (2012)
Stereotactic body radiation therapy for the primary treatment of localized prostate cancerJournal of Radiation Oncology, 2
-
Leonard Chen, S. Suy, Hongkun Wang, Aditi Bhagat, J. Woo, Rudy Moures, Joy Kim, T. Yung, S. Lei, B. Collins, K. Kowalczyk, A. Dritschilo, J. Lynch, S. Collins (2014)
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerRadiation Oncology (London, England), 9
-
C. Mantz (2014)
A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-UpFrontiers in Oncology, 4
-
M. Hallek (2018)
Prostate CancerNursing standard (Royal College of Nursing (Great Britain) : 1987), 30 40
-
S. Arcangeli, C. Greco (2016)
Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?Nature Reviews Urology, 13
-
(2012)
Cost-effectiveness analysis of SBRT versus IMRT: an emerging initial radiation treatment option for organ-confined prostate cancerAm J Manag Care, 18
-
Jorgo Kliton, P. Ágoston, Z. Szabó, T. Major, C. Polgár (2014)
[Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: side effects caused by the marker implantation].Magyar onkologia, 58 3
-
S. McBride, D. Wong, J. Dombrowski, B. Harkins, P. Tapella, H. Hanscom, S. Collins, I. Kaplan (2012)
Hypofractionated stereotactic body radiotherapy in low‐risk prostate adenocarcinomaCancer, 118
-
M. Anwar, V. Weinberg, Z. Seymour, I. Hsu, M. Roach, A. Gottschalk (2016)
Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancerRadiation Oncology (London, England), 11
-
V. Murthy, S. Sinha, S. Kannan, D. Datta, Rabi Das, G. Bakshi, G. Prakash, R. Krishnatry (2019)
Safety of Prostate Stereotactic Body Radiation Therapy after Transurethral Resection of Prostate (TURP): A Propensity Score Matched Pair Analysis.Practical radiation oncology
-
S. Dandapani, M. Sanda (2008)
Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer.Seminars in radiation oncology, 18 1
-
R. Hannan, V. Tumati, Xian-Jin Xie, L. Cho, Brian Kavanagh, J. Brindle, D. Raben, A. Nanda, S. Cooley, D.W. Kim, D. Pistenmaa, Y. Lotan, R. Timmerman (2016)
Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.European journal of cancer, 59
-
Eric Holmboe, John Concato (2000)
Treatment decisions for localized prostate cancerJournal of General Internal Medicine, 15
-
G. Bolzicco, M. Favretto, N. Satariano, E. Scremin, C. Tambone, A. Tasca (2013)
A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapyBMC Urology, 13
-
D. Dearnaley, I. Syndikus, H. Mossop, V. Khoo, A. Birtle, D. Bloomfield, J. Graham, P. Kirkbride, J. Logue, Z. Malik, J. Money-Kyrle, J. O’Sullivan, M. Panades, C. Parker, H. Patterson, C. Scrase, J. Staffurth, A. Stockdale, Jean Tremlett, M. Bidmead, H. Mayles, O. Naismith, C. South, A. Gao, C. Cruickshank, S. Hassan, J. Pugh, C. Griffin, E. Hall (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet. Oncology, 17
-
A. Katz, M. Santoro, R. Ashley, F. Diblasio, M. Witten (2010)
Stereotactic body radiotherapy for organ-confined prostate cancerBMC Urology, 10
-
M. Gurka, Leonard Chen, Aditi Bhagat, Rudy Moures, Joy Kim, T. Yung, S. Lei, B. Collins, P. Krishnan, S. Suy, A. Dritschilo, J. Lynch, S. Collins (2015)
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerRadiation Oncology (London, England), 10
-
D. Freeman, C. King (2011)
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomesRadiation Oncology (London, England), 6
-
B. Madsen, R. Hsi, H. Pham, J. Fowler, L. Esagui, J. Corman (2007)
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results.International journal of radiation oncology, biology, physics, 67 4
-
A. Heidenreich, P. Bastian, J. Bellmunt, M. Bolla, S. Joniau, T. Kwast, M. Mason, V. Matveev, T. Wiegel, F. Zattoni, N. Mottet (2014)
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.European urology, 65 1
-
D. Brand, A. Tree, P. Ostler, H. Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, Alexander Martin, J. Staffurth, P. Camilleri, K. Kancherla, J. Frew, A. Chan, I. Dayes, D. Henderson, S. Brown, C. Cruickshank, S. Burnett, A. Duffton, C. Griffin, V. Hinder, K. Morrison, O. Naismith, E. Hall, N. As (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trialThe Lancet. Oncology, 20
-
K. Jorgo, P. Ágoston, T. Major, Z. Takácsi-Nagy, C. Polgár (2017)
Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancerStrahlentherapie und Onkologie, 193
-
S. Jabbari, V. Weinberg, T. Kaprealian, I. Hsu, Lijun Ma, C. Chuang, M. Descovich, S. Shiao, K. Shinohara, M. Roach, A. Gottschalk (2012)
Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.International journal of radiation oncology, biology, physics, 82 1
-
F. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, Tim Peters, E. Turner, Richard Martin, J. Oxley, M. Robinson, J. Staffurth, E. Walsh, P. Bollina, J. Catto, A. Doble, A. Doherty, D. Gillatt, R. Kockelbergh, H. Kynaston, A. Paul, P. Powell, S. Prescott, D. Rosario, E. Rowe, D. Neal, D. Neal (2017)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.The New England journal of medicine, 375 15
-
(2016)
Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancerN Engl J Med, 375
-
Kyle Wang, Ronald Chen, B. Kane, C. Medbery, K. Underhill, J. Gray, A. Peddada, D. Fuller (2018)
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial.International journal of radiation oncology, biology, physics, 102 5
-
F. Bray, J. Ferlay, I. Soerjomataram, R. Siegel, Lindsey Torre, A. Jemal (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 68
-
E. Holmboe, J. Concato (2000)
Treatment Decisions for Localized Prostate Cancer Asking Men What ’ s Important -
(2016)
Prostate cancerLancet, 387
-
(2023)
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.The New England journal of medicine, 388 23
-
W. Lee, J. Dignam, M. Amin, D. Bruner, D. Low, G. Swanson, A. Shah, D. D'Souza, J. Michalski, I. Dayes, S. Seaward, W. Hall, P. Nguyen, T. Pisansky, S. Faria, Yuhchyau Chen, B. Koontz, R. Paulus, H. Sandler (2016)
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 20
-
Lindsey Torre, R. Siegel, E. Ward, A. Jemal (2015)
Global Cancer Incidence and Mortality Rates and Trends—An UpdateCancer Epidemiology, Biomarkers & Prevention, 25
-
C. Catton, H. Lukka, C. Gu, Jarad Martin, S. Supiot, P. Chung, G. Bauman, J. Bahary, Shahida Ahmed, P. Cheung, K. Tai, Jackson Wu, M. Parliament, T. Tsakiridis, T. Corbett, Colin Tang, I. Dayes, P. Warde, Tim Craig, J. Julian, M. Levine (2017)
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 17
-
S. McBride, D. Wong, J. Dombrowski, B. Harkins, P. Tapella, H. Hanscom, S. Collins, I. Kaplan (2011)
Hypofractionated Stereotactic Body Radiotherapy in Low Risk Prostate Adenocarcinoma: Preliminary Results of a Multi-Institutional Phase I Feasibility TrialInternational Journal of Radiation Oncology Biology Physics, 81
-
S. Aluwini, Peter Rooij, M. Hoogeman, W. Kirkels, I. Kolkman-Deurloo, C. Bangma (2013)
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsRadiation Oncology (London, England), 8
-
(2016)
Global cancer incidence and mortality rates and trends – an updateCancer Epidemiol Biomarkers Prev, 25
-
(2011)
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancerJ Clin Oncol, 29
- Publisher
- de Gruyter
- Copyright
- © 2021 Kliton Jorgo, Csaba Polgar, Gabor Stelczer, Tibor Major, Laszlo Gesztesi, Peter Agoston, published by Sciendo
- ISSN
- 1581-3207
- eISSN
- 1581-3207
- DOI
- 10.2478/raon-2021-0031
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Radiology and Oncology – de Gruyter
Published: Jul 13, 2021
Keywords: prostate cancer; stereotactic radiotherapy; CyberKnife; extreme hypofractionation